Advertisements

Dr.Reddy"s Laboratories launches generic version of Suboxone

Dr.Reddy"s Laboratories launches generic version of Suboxone.....»»

Category: topSource: the-hinduJun 15th, 2018

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Dr Reddy#39;s Laboratories launches Tetrabenazine tablet in US market

Dr Reddy#39;s Laboratories launches Tetrabenazine tablet in US market.....»»

Category: topSource: moneycontrolFeb 2nd, 2018

Dr Reddy#39;s launches Sevelamer Carbonate tablets in US

Dr Reddy#39;s launches Sevelamer Carbonate tablets in US.....»»

Category: topSource: moneycontrolSep 30th, 2017

Dr Reddy"s launches new generic drug; Stock fails to retain early gains

Dr Reddy"s launches new generic drug; Stock fails to retain early gains.....»»

Category: marketsSource: sifyOct 3rd, 2017

Dr.Reddy"s launches two generic drugs in U.S.

Dr.Reddy"s launches two generic drugs in U.S......»»

Category: topSource: the-hinduSep 6th, 2017

Dr Reddy’s gets favourable verdict in patent litigation in US

Dr Reddy’s gets favourable verdict in patent litigation in US.....»»

Category: featuresSource: livemintSep 1st, 2017

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

Indivior shares dive after Dr Reddy"s gets FDA approval for generic

Indivior shares dive after Dr Reddy"s gets FDA approval for generic.....»»

Category: global-financeSource: reutersJun 15th, 2018

Dr. Reddy"s fourth-quarter profit falls 19 percent on U.S. headwinds

Dr. Reddy"s fourth-quarter profit falls 19 percent on U.S. headwinds.....»»

Category: global-financeSource: reutersMay 22nd, 2018

Dr. Reddy"s fourth-quarter profit falls about 19 percent, misses estimates

Dr. Reddy"s fourth-quarter profit falls about 19 percent, misses estimates.....»»

Category: global-financeSource: reutersMay 22nd, 2018

Dr. Reddy"s fourth-quarter profit falls 3 percent, misses estimates

Dr. Reddy"s fourth-quarter profit falls 3 percent, misses estimates.....»»

Category: global-financeSource: reutersMay 22nd, 2018

Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Spray

Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Spray.....»»

Category: topSource: moneycontrolMar 27th, 2018

Dr. Reddy"s Q3 profit tumbles, hit by U.S. pricing pressure

Dr. Reddy"s Q3 profit tumbles, hit by U.S. pricing pressure.....»»

Category: global-financeSource: reutersJan 25th, 2018

Lupin launches generic anti-infection capsules in US

Lupin launches generic anti-infection capsules in US.....»»

Category: featuresSource: livemintJan 5th, 2018

Mylan launches MS drug in US

Mylan launches MS drug in US.....»»

Category: topSource: the-hinduOct 5th, 2017

Dr Reddy"s Labs jumps over 3%

Dr Reddy"s Labs jumps over 3%.....»»

Category: marketsSource: thehindubusinesslineOct 3rd, 2017

Dr Reddy"s launches key kidney ailment drug

Dr Reddy"s launches key kidney ailment drug.....»»

Category: featuresSource: business-standardOct 1st, 2017

U.S. court rules in favour of Dr. Reddy’s in patent litigation

U.S. court rules in favour of Dr. Reddy’s in patent litigation.....»»

Category: topSource: the-hinduSep 1st, 2017